EICHOR
● Recruiting
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
Condition: Esophageal Squamous Cell Carcinoma · Sponsor: Henan Cancer Hospital
About this study
This is a Phase III, multicenter, open-label, randomized controlled trial. The study aims to compare organ preservation versus esophagectomy in patients with locally advanced, resectable thoracic esophageal squamous cell carcinoma (ESCC) who achieve a complete or partial clinical response (cCR/cPR) following neoadjuvant immunochemotherapy.
This description comes directly from the study's public registry record.
Talk to the study team
Yan Zheng, M.D./Ph.D · (+86)0371-65587610 · hnszlyylixiang@163.com
Song · (+86)0371-65587610 · hnszlyylixiang@163.com
Always discuss trial participation with your own doctor first.
Locations (1)
| Henan Cancer Hospital | Zhengzhou, Henan, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07629817